Important Legal & Medical Disclaimer Not Medical Advice This article is provided solely for educational purposes
Noom aims to make meal planning more manageable and personalized with the Welli Meal Planner
Meanwhile, Novo Nordisk has submitted its oral semaglutide tablet (oral Wegovy) for weight-management indication, reporting ~15% weight loss in a ~64-68-week study
The platform tends to skew younger, more male, and more U.S.-based than the broader population of people taking GLP-1 medications
Our dedicated team is here to support your journey toward a healthier, more active lifestyle
Yes GLP-1 medications were originally developed for type 2 diabetes and have strong evidence for improving blood sugar, reducing A1C, and protecting cardiovascular and kidney health